Artigos Científicos
HBsAg Quantitativo (Clareamento do HBsAg) Voltar
- HBsAg Quantitativo Sistema ARCHITECT / Abbott (Clareamento do HBsAg)
- In Patients With HBeAg-Negative Chronic Hepatitis B, HBsAg Serum Levels Early During Treatment With Peginterferon Alfa-2a Predict HBsAg Clearance up to 4 Years Post-Treatment
- Early Serum HBsAg Drop: A Strong Predictor of Sustained Virological Response to Pegylated Interferon Alfa-2a in HBeAg-Negative Patients
- HBsAg Profiles in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses
- Correlation of Quantitative Assay of HBsAg and HBV DNA Levels During Chronic HBV Treatment
- Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay
- Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B
- INTRODUCTION OF AN AUTO-DILUTION FOR ARCHITECT HBsAg QUANTITATIVE ASSAY
- Hepatitis B Surface Antigen Quantification as a Current-Day Paradox: Obtaining the Gold in the Face of Diminishing Returns
- New endpoints. Back to the future with Australia Antigen
